Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart BDR | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$4.51T | 40.8x | 1.55 | R$35.12 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger Co | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$274.67B | 18.3x | 0.75 | R$415.10 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano DRC | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$209.39B | 26.6x | 0.55 | R$558 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$194.04B | 18.4x | -3.15 | R$218.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RAIADROGASIL ON | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$33.35B | 26.6x | 1.76 | R$19.45 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.2% Upside | Upgrade to Pro+ | |
Atacadao | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$18.24B | 10.4x | 0.03 | R$8.68 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.1% Downside | Upgrade to Pro+ | |
Grupo Mateus | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$17.31B | 10.4x | 1.6 | R$7.68 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.9% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$12.48B | 12.6x | 1.95 | R$9.03 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.2% Downside | Upgrade to Pro+ | |
Almacenes | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$3.38B | 46.4x | -0.82 | R$9.45 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pague Menos | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.87B | 39,024.4x | R$3.35 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.6% Upside | Upgrade to Pro+ | ||
Brasileira De Dist | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.87B | -0.7x | -0.03 | R$3.04 | -20.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.8% Downside | Upgrade to Pro+ | |
Dimed | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.36B | 12.6x | 0.99 | R$9.08 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
D1000 On | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$314.75M | 11.3x | 0.56 | R$5.56 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ |